Revisiting the Need for Vaccine Prevention of Late-Onset Neonatal Group B Streptococcal Disease

Abstract

The late-onset GBS disease burden remains substantial. A trivalent vaccine could be an effective prevention strategy. Because many cases were born preterm, reducing the opportunity for transplacental antibody transfer, adolescent immunization should be considered.